Article - Page 4 of 6 - Echosens

Choose your location

Choose your language

New EASL Clinical Practice Guidelines Make Unprecedented Recommendation for Non-Invasive FibroScan^® and Care Management

Douglas Dieterich, M.D., discusses role of FibroScan^® in the diagnoses of chronic liver disease

Non-Invasive Liver Exam Identifies Asymptomatic Liver Disease, Provides Follow-Up for Hepatitis C Virus

NICE Experts Endorse FibroScan^®: Cost-Effective Liver Exam

Lancet Study: FibroScan^® Identifies Severe Fibrosis/Cirrhosis for Earlier Diagnosis

Population-Based Return on Investment of Deploying Transient Elastography

Echosens CEO Discusses How Company Helps Fight Liver Disease Epidemic

Celebrating 2 decades of liver health

Help Support First Annual Liver Health Matters Month!

Research Featured as Cover Story in April Issue of Clinical Gastroenterology & Hepatology Demonstrates FibroScan^®’s Ability to Monitor Liver-related Events and Survival

Phone
This field is for validation purposes and should be left unchanged.
Country*
Email*
By subscribing, I agree that Echosens collects and uses my data in accordance with the Privacy Policy.